VERIGRAFT
VERIGRAFT generates personalized tissue-engineered transplants for use in regenerative medicine. The company’s unique technology platform turns donated allogeneic (“foreign”) tissue into an autologous-like (“personalized”) tissue and thus avoids transplant rejection and the need for life-long immunosuppression.
Gothenburg, Swedenverigraft.com ↗
Total raised
€1.2M
€1,200,000
Funding rounds
1
Investors
1
distinct backers
Active since
2025-02
latest 2025-02
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood50
base rate 45% for Grant
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-14 | Grant | €1.2M | EuroStars | View deal → |